论文部分内容阅读
目的:评估长江流域6城市抗高血压药使用特点及用药趋势。方法:采用购药金额排序法,对临床常用的6大类抗高血压药在6城市的销售情况、所占百分比和重点药品等进行分析。结果:6城市抗高血压药的销售金额呈上升趋势,其中上海、南京和杭州增长较高,武汉、成都和重庆增长相对较低。钙通道阻滞药用量约占抗高血压药的50 % ,血管紧张素转换酶抑制药约占25 % ,血管紧张素Ⅱ受体拮抗药约占10%。结论:钙通道阻滞药、血管紧张素转换酶抑制药和血管紧张素Ⅱ受体拮抗药为临床用量最大的3类抗高血压药,其它3类药物临床用量较少,生产企业应予关注。
Objective: To evaluate the characteristics and medication trends of antihypertensive drugs in 6 cities in the Yangtze valley. Methods: Using the order of the purchase amount of drugs, the analysis of the sales, the percentage of the 6 major antihypertensive drugs commonly used clinically in 6 cities and the key drugs were analyzed. Results: The sales volume of antihypertensive drugs in 6 cities showed an upward trend. Among them, the growth rates in Shanghai, Nanjing and Hangzhou were relatively high while the growth rates in Wuhan, Chengdu and Chongqing were relatively low. Calcium channel blockers account for about 50% of antihypertensive drugs, angiotensin converting enzyme inhibitors account for about 25%, angiotensin Ⅱ receptor antagonists account for about 10%. Conclusion: Calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin Ⅱ receptor antagonists are the three types of antihypertensive drugs with the largest clinical dosage. The other three types of drugs are less in clinical dosage, and the manufacturers should pay attention .